| Scott Glen King, MPT | |
|
103 S Commercial Ave, Emmett, ID 83617-2921 | |
| (208) 477-8028 | |
| Not Available |
| Full Name | Scott Glen King |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 21 Years |
| Location | 103 S Commercial Ave, Emmett, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053648923 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-1924 (Idaho) | Primary |
| Provider Name | King Physical Therapy P.c. |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1891000386 PECOS PAC ID: 8628192424 Enrollment ID: O20100831000822 |
News Archive
A study in the current issue of Psychotherapy and Psychosomatics outlines some novel insights between cardiac vagal activity [heart rate variability in the high-frequency band (HRV-HF)] and symptoms that do not find an organic explanation.
A new drug for a type of skin cancer caused by a rare genetic disease can not only substantially shrink the tumors, but can also prevent the growth of new cancers, US investigators have discovered.
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC).
Seattle Children's today announced two transformative philanthropic gifts totaling $65 million to benefit pediatric research, nursing education and clinical care.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Glen King, MPT Po Box 1056, Emmett, ID 83617-1056 Ph: (208) 477-8028 | Scott Glen King, MPT 103 S Commercial Ave, Emmett, ID 83617-2921 Ph: (208) 477-8028 |
News Archive
A study in the current issue of Psychotherapy and Psychosomatics outlines some novel insights between cardiac vagal activity [heart rate variability in the high-frequency band (HRV-HF)] and symptoms that do not find an organic explanation.
A new drug for a type of skin cancer caused by a rare genetic disease can not only substantially shrink the tumors, but can also prevent the growth of new cancers, US investigators have discovered.
Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC).
Seattle Children's today announced two transformative philanthropic gifts totaling $65 million to benefit pediatric research, nursing education and clinical care.
› Verified 1 days ago
Emme Warnken, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 809 S Washington Ave, Emmett, ID 83617 Phone: 208-365-5341 | |
Kenneth J Murdock, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 809 S Washington Ave, Emmett, ID 83617 Phone: 208-365-5341 Fax: 208-365-5343 | |
Brandon Scott Sallee, Physical Therapist Medicare: Medicare Enrolled Practice Location: 809 S Washington Ave, Emmett, ID 83617 Phone: 208-365-5341 Fax: 208-365-5342 | |
Mr. Steven Gerald Balle, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 714 N Butte Ave, Emmett, ID 83617 Phone: 208-365-4425 | |
Kathryn Margaret Phillips, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 809 S Washington Ave, Emmett, ID 83617 Phone: 208-365-5341 | |
Michelle Holt, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 809 S Washington Ave, Emmett, ID 83617 Phone: 208-365-5341 Fax: 208-365-5342 |